TrialJournal of experimental & clinical cancer research : CR2009

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

Luigi Di Lauro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.